More than $ 12 million in grants for breast cancer research will help save lives and revolutionize screening and treatment in Australia, experts say.
The National Breast Cancer Foundation (NBCF) has announced funding for nearly $ 12.4 million for 20 research projects as part of a campaign to achieve “zero death from breast cancer” by 2030.
“Over the past 28 years, NBCF has significantly improved breast cancer outcomes in Australia through its grant program,” said Associate Professor Cleola Anderies, NBCF CEO.
“I am proud to provide the 20 additional talented researchers and their staff with the support they need to work on the NBCF’s zero-death mission from breast cancer by 2030.”
Breast cancer is one of the most commonly diagnosed cancers in Australia and affects both men and women, according to the Australian Institute of Health and Welfare.
This year alone, an estimated 20,000 people will be diagnosed, and every day nine Australians die from the disease.
Sarah Singer, a mother of two in Melbourne and a breast cancer survivor, said organizations like NBCF, which counts on government donations, give her a sense of hope.
“When I was first diagnosed almost 20 years ago, the world just collapsed,” she said.
“You hear,‘ You have breast cancer, ’and you’re 32 years old with a 16-month-old baby, I just couldn’t imagine having a future.
“I have the BRCA gene, and at the moment I don’t know if my two daughters have it. Various research projects will help make them a better future if they themselves are in the same position I was in when I was 32. “
Grant recipients include the University of Melbourne, UNSW Sydney and the Garvan Institute for Medical Research, which will evaluate new epigenetic blood tests to detect and monitor breast cancer.
Monash University professor Tony Tiganis said the funding would greatly help his research on the use of immunotherapy to treat breast cancer in obesity.
“We learned from Covid that if there are enough resources for the problem from a scientific point of view, we can really come up with some innovative solutions, and we need to work on that with breast cancer and fund research to develop treatments,” he said. said Tiganis.
“Two-thirds of our population is overweight or obese, and most patients with triple-negative breast cancer are overweight or obese.
“We know that obesity is a marker of poor prognosis in breast cancer and can contribute to the development and potentially affect the treatment of various cancers.”